Birchview Capital »

Pharvaris N V shares owned by Birchview Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Birchview Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $828k 30k 27.75
2025-09-30 $370k 15k 24.95

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Compass Therapeutics (CMPX)
Stoke Therapeutics (STOK)
Lam Research Corporation Com New (LRCX)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Spons Adr (GPCR)
Protagonist Therapeutics (PTGX)
ACADIA Pharmaceuticals (ACAD)
Encana Corporation (OVV)
Prothena Corp SHS (PRTA)
Solid Biosciences Com New (SLDB)
Neurocrine Biosciences (NBIX)
Amicus Therapeutics (FOLD)
Bicycle Therapeutics Sponsored Ads (BCYC)

View all positions for Birchview Capital

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Commodore Capital
Novo A/S
Wellington Management Company
Saturn V Capital Management
Cormorant Asset Management
5AM Venture Management
Sofinnova Ventures

View all funds holding Pharvaris N V